D165-0130 Screening compound: 4-[7-ethyl-2-(4-fluorophenyl)-1H-1,3,5-benzotriazepin-4-yl]-N,N-dimethylaniline

D165-0130 Screening compound: 4-[7-ethyl-2-(4-fluorophenyl)-1H-1,3,5-benzotriazepin-4-yl]-N,N-dimethylaniline
D165-0130 Screening compound: 4-[7-ethyl-2-(4-fluorophenyl)-1H-1,3,5-benzotriazepin-4-yl]-N,N-dimethylaniline alternative view

Chemical Structure Depiction of ChemDiv screening compound D165-0130
4-[7-ethyl-2-(4-fluorophenyl)-1H-1,3,5-benzotriazepin-4-yl]-N,N-dimethylaniline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D165-0130

Molecular Formula

C24H23FN4 (C24 H23 FN4)

Compound Name

4-[7-ethyl-2-(4-fluorophenyl)-1H-1,3,5-benzotriazepin-4-yl]-N,N-dimethylaniline

IUPAC name

4-[7-ethyl-2-(4-fluorophenyl)-1H-135-benzotriazepin-4-yl]-NN-dimethylaniline

SMILES

CCc(cc1)cc2c1NC(c(cc1)ccc1F)=NC(c(cc1)ccc1N(C)C)=N2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.47

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.609

Distribution Coefficient, logD

5.601

Water Solubility, LogSw

-5.55

Polar Surface Area

34.280

Acid Dissociation Constant (pKa)

11.42

Base Dissociation Constant (pKb)

5.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

D165-0130 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Others
  • Phosphatases
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with D165-0130 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D165-0130?
Check Price and Availability of D165-0130, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D165-0130 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D165-0130
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D165-0130
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D165-0130 available by request